NuVasive, Inc. v. Rival Medical, LLC

CourtDistrict Court, D. Massachusetts
DecidedJune 14, 2023
Docket1:21-cv-11644
StatusUnknown

This text of NuVasive, Inc. v. Rival Medical, LLC (NuVasive, Inc. v. Rival Medical, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NuVasive, Inc. v. Rival Medical, LLC, (D. Mass. 2023).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

NUVASIVE, INC., Plaintiff,

v. CIVIL ACTION NO. 21-11644-DJC

RIVAL MEDICAL, LLC, et al., Defendants.

MEMORANDUM AND ORDER ON PLAINTIFF’S MOTION TO COMPEL (#61).

KELLEY, U.S.M.J.

I. Introduction.

This lawsuit arises out of an arbitration award that defendant Rival Medical, LLC has refused to pay plaintiff NuVasive, Inc. NuVasive alleges that co-defendants Timothy Day (“Day”), Rival Medical’s registered agent in Massachusetts, and Monique Day, Rival Medical’s manager, abused the corporate form such that Rival Medical’s liability should be imposed on them. NuVasive brings claims to pierce the corporate veil, impose alter ego liability, and for fraudulent transfer. (#1 ¶¶3-4, 17-18, 22, 39-65.) This court has issued two previous orders rejecting defendants’ objections to third-party subpoenas served by NuVasive in support of its claims. (#31, Bank of America; #41, Roy & Rurak, LLC). In this order, the court rejects defendants’ objection to the third-party subpoena to Alphatec Spine, Inc. (#65), and allows NuVasive’s motion to compel compliance. (#61); see #60. II. History of the Case. The complaint was filed on October 8, 2021. (#1.) Initially, fact discovery was scheduled to close on November 30, 2022, and motions for summary judgment were due by January 17, 2023. (##19, 20.) Defendants filed the motion to quash the Bank of America subpoena on February 14, 2022 (#21), and the court denied the motion on March 15. (#31.) NuVasive filed the motion to

compel compliance with the Roy & Rurak, LLC subpoena on April 21 (#36), and the court allowed the motion on May 16. (#41.) In the interim, NuVasive filed a motion to compel defendants to fully respond to interrogatories and requests for production of documents (#38), which the court allowed on May 18. (#43.) Before the expiration of the fact discovery deadline, NuVasive moved to modify the court’s original scheduling order. (#44.) Defendants did not oppose the motion. See #44 at 5. Judge Casper allowed the motion, extending the fact discovery deadline to January 30, 2023, and the summary judgment deadline to March 17. (#45.) On March 15, 2023, NuVasive requested an extension of the summary judgment deadline “in order to re-open and complete Mr. Day’s deposition.” (#47 at 2) (“the March 15 motion”). NuVasive represented that, on February 20, counsel for NuVasive in actions before Delaware1 and

California2 courts notified counsel for NuVasive in this action about the production of discovery in the other actions indicating that Day used a cell phone number in 2018 and 2019 that had not been previously identified in discovery. The production included text messages between Day and Alphatec’s Chief Executive Officer, Patrick Miles, in 2018 and 2019 (“the Day-Miles text messages”). In the March 15 motion, NuVasive argued that the Day-Miles text messages were

1 NuVasive, Inc. v. Patrick Miles, et al., No. 2017-0720-SG (Del. Chan.).

2 Alphatec Spine, Inc. v. NuVasive, Inc., Lead Case No. 3-2017-00038583-CUBPT-CLT (Cal. Super.) relevant to Day’s decision to leave NuVasive, shutter Rival Medical’s operations, and transition to Alphatec, and thus to NuVasive’s claim that Rival Medical’s corporate veil should be pierced. (#47 at 3-4, 7.) Before filing the March 15 motion, NuVasive’s counsel in this action contacted defense counsel twice, to no avail. On March 6, NuVasive’s counsel emailed defense counsel about the

newly-disclosed cell phone number and the need to re-open Day’s deposition. Defense counsel did not respond. (#47 at 4); see #47-1 at 2-3. On March 13, counsel emailed defense counsel about the need to extend the summary judgment deadline. Defense counsel did not respond. (#47 at 4); see #47-1 at 2. In opposition to the March 15 motion, defendants argued that NuVasive had not identified the newly-disclosed cell phone number in the motion or attached to the motion the Day-Miles text messages or the discovery responses in which Day allegedly misrepresented his cell phone numbers. NuVasive thus “failed to demonstrate the necessity for further discovery” and “diligen[ce]” in this action. (#49 at 2-3.) Judge Casper allowed the March 15 motion:

Having reviewed the motion, D. 47, and the opposition, D. 49, the Court ALLOWS the motion for extension for 45 days until 5/22/23 for NuVasive to reopen Day’s deposition and file a dispositive motion.

(#51.) On May 19, NuVasive requested another extension of the summary judgment deadline as well as an order directing Day to sit for the re-opened deposition. (#59 at 1-2) (“the May 19 motion”); see #60. Defendants oppose the May 19 motion (#63), which remains pending and has not been referred to this court. NuVasive filed the present motion to compel compliance with the Alphatec subpoena on May 30, relying on its memorandum in support of the May 19 motion. (#61 at 2.) NuVasive’s memorandum and exhibits establish this chronology: Six days after Judge Casper allowed the March 15 motion, on April 11, NuVasive’s counsel emailed defense counsel about dates on which to complete Day’s re-opened deposition. (#60-1 at 2.) On April 17, NuVasive’s counsel emailed Alphatec’s counsel requesting permission to use twenty-one documents produced in the Delaware and California actions, including the Day-Miles

text messages, in the hope of avoiding a subpoena. (#60-6 at 4-5.) By April 24, Alphatec’s counsel had not responded, so NuVasive’s counsel followed up by indicating that NuVasive would serve an attached subpoena absent an informal agreement regarding the twenty-one documents plus three additional documents produced in the Delaware and California actions. (#60-6 at 3-4.) In the emails, NuVasive’s counsel identified the twenty-four total documents by Bates number. Id. at 3- 5. On April 25, Alphatec’s counsel instructed NuVasive’s counsel to serve a subpoena. (#60- 6 at 3.) That same day, NuVasive’s counsel did so, formally seeking production of the twenty-four documents produced in the Delaware and California actions, including the Day-Miles text

messages. Id.; see #60-7 at 5. NuVasive describes the other twenty-three documents as emails, some with attachments, call-in information, and text messages. Id. at 4-5.3 On May 5, Alphatec’s counsel emailed NuVasive’s counsel about an extension of time to serve responses and objections to the subpoena. (#60-6 at 2.) NuVasive’s counsel questioned the need for an extension and offered to discuss on the phone. Id. That same day, Alphatec’s counsel

3 The court understands the subpoenaed documents to be subject to protective order in the Delaware and California actions. (#60 at 5); see #47 at 4. Although some of the emails involved lawyers, see id. at 4-5, there is no developed argument that the subpoenaed documents are privileged. As discussed below, Alphatec no longer objects to their production, and defendants’ only argument is that the subpoena was served after close of discovery without prior leave. served the responses and objections. (#60-8 at 21.) Alphatec argued, inter alia, that the subpoena was vague and burdensome and that the subpoenaed documents were irrelevant. Id. at 2-20. Now, in response to the present motion, Alphatec states that it has “no objection” to production of the subpoenaed documents and will “immediately” produce them if the court rejects defendants’ objections. (#66 at 1.)

Defendants raise just one objection: The Court should deny NuVasive’s Motion to Compel Alphatec, Inc. to provide documents responsive to the subpoena duces tecum because discovery in this case had expired on January 30, 2023 with the sole exception to “reopen Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Alex J. Raineri
670 F.2d 702 (Seventh Circuit, 1982)
Tubens v. Doe
976 F.3d 101 (First Circuit, 2020)
Alper v. United States
190 F.R.D. 281 (D. Massachusetts, 2000)
Williamson v. Horizon Lines LLC
248 F.R.D. 79 (D. Maine, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
NuVasive, Inc. v. Rival Medical, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nuvasive-inc-v-rival-medical-llc-mad-2023.